Depression and anxiety affect approximately 40% of adults with chronic pain, according to a massive new systematic review and meta-analysis published in JAMA Network Open. The comprehensive study ...

Mind Medicine ($MNMD) announced its Q4 financials and indicated it is making strides in developing innovative treatments for ...

Johnson & Johnson JNJ decided to discontinue the Phase 3 VENTURA development program, which is evaluating aticaprant as an ...

Johnson & Johnson (JNJ) announced last night its decision to discontinue the Phase 3 VENTURA development program evaluating aticaprant as ...

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...

New research shows how gut serotonin impacts mood and SSRI effects, offering insights into targeted antidepressant treatments ...

Health experts say most people who die by suicide have a mental health issue which might likely be depressive or substance ...

Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.

The depression treatment market is experiencing steady growth, driven by rising mental health awareness, increasing prevalence of depression, and advancements in novel therapies. The market is ...

Objective This study aimed to investigate the incidence of overweight in patients with major depressive disorder (MDD) ...

with method claims pertaining to treatment of major depressive disorder (MDD) in patients with inadequate response to an antidepressant. The method includes treatment with ALTO-300 as an ...